Skip to content

Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated Ophthalmopathy

The Therapeutic Effect of Combination of Orbital Compression Surgery and Strabismus Surgery in Patients With Moderate to Severe Thyroid Associated Ophthalmopathy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04919694
Enrollment
60
Registered
2021-06-09
Start date
2021-07-01
Completion date
2023-12-31
Last updated
2021-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Associated Ophthalmopathy

Brief summary

The purpose of this study is to determine whether combination of orbital compression surgery with strabismus surgery is better than strabismus surgery after orbital compression surgery in the treatment of moderate-to-severe thyroid associated ophthalmopathy

Detailed description

This study will be a interventional case series. Patients with moderate-to-severe thyroid associated ophthalmopathy will be randomized to receive combination of orbital compression surgery with strabismus surgery or strabismus surgery after orbial compression surgery.Patients will be followed for 6 months.

Interventions

PROCEDUREcombination of orbital compression surgery and strabismus surgery

combination of orbital compression surgery and strabismus surgery at the same time

PROCEDUREorbital compression

orbital compression

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* moderate-to-severe thyroid associate ophthalmopathy * CAS≤3 score * monocular strabismus,deviation≥20° or 35▲ * stable thyroid function for at least 6 months, confirmed by an endocrinologist

Exclusion criteria

* any previous disease in the study eye. * any previous systematic disease

Design outcomes

Primary

MeasureTime frameDescription
quality of life ,measured by GO-QoL(quality of life with Grave's Orbitopathy) .6 weeks after surgeryAll GO-QoL questions were scored as 'severely limited' (one point), 'a little limited' (two points) or 'not limited at all' (three points). The questions 1-8 for visual functioning (VF) and questions 9-16 for appearance (AP)were summed to produce two raw scores from 8 to 24 points and then transformed to two total scores from 0 to 100 by the following formula: total score = \[(raw score - 8)/16 9 100\]. In both cases, higher total scores indicate better QoL. When there were missing values, total scores were calculated for the remaining completed items. The transformation was then adjusted to total score = \[(raw score - \*)/(2x\*) x100\] where \* is the number of completed items.
quality of life, measured by GO-QoL(quality of life with Grave's Orbitopathy) .6 monthsAll GO-QoL questions were scored as 'severely limited' (one point), 'a little limited' (two points) or 'not limited at all' (three points). The questions 1-8 for visual functioning (VF) and questions 9-16 for appearance (AP)were summed to produce two raw scores from 8 to 24 points and then transformed to two total scores from 0 to 100 by the following formula: total score = \[(raw score - 8)/16 9 100\]. In both cases, higher total scores indicate better QoL. When there were missing values, total scores were calculated for the remaining completed items. The transformation was then adjusted to total score = \[(raw score - \*)/(2x\*) x100\] where \* is the number of completed items.

Secondary

MeasureTime frameDescription
strabismus status6 weeks after surgeryangle of deviation including up-gaze, down-gaze ,left and right-gaze

Countries

China

Contacts

Primary ContactHua sheng Yang, M.D,PHD
yanghs64@162.com+8620-87331539

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026